Reply to A. Mangla
- PMID: 37441743
- PMCID: PMC10581606
- DOI: 10.1200/GO.23.00145
Reply to A. Mangla
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
No potential conflicts of interest were reported.
References
-
- Mangla A. Should neoadjuvant treatment be adopted more widely for patients with extremity soft tissue sarcoma in low-income countries? JCO Glob Oncol. 10.1200/GO.23.00110 - DOI - PMC - PubMed
-
- Raza SM, Riaz A, Mansha MA, et al. Radiotherapy and limb-sparing surgery in the management of localized soft tissue sarcomas: Tertiary care center experience from Pakistan. JCO Glob Oncol. 2023 10.1200/GO.22.00047 - DOI - PMC - PubMed
-
- Abbasi AN. Establishment and maintenance of quality of site-specific multidisciplinary tumor boards in Pakistan. J Coll Physicians Surg Pak. 2016;26:805–807. - PubMed
-
- Cormier JN, Huang X, Xing Y, et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol. 2004;22:4567–4574. - PubMed
LinkOut - more resources
Full Text Sources